Study Summary
This trialwill test if VOB560 and MIK665 can safely be given together and if it can help treat NHL, MM or AML.
- Non-Hodgkin's Lymphoma
- Multiple Myeloma
- Acute Myeloid Leukemia
Treatment Effectiveness
Effectiveness Progress
Study Objectives
5 Primary · 15 Secondary · Reporting Duration: at month 18
Trial Safety
Safety Progress
Trial Design
6 Treatment Groups
VOB560-MIK665 - Part 2a
1 of 6
VOB560-MIK665 - Part 2b
1 of 6
VOB560-MIK665 - Part 1b
1 of 6
VOB560-MIK665 - Part 1a
1 of 6
VOB560-MIK665 - Part 2d
1 of 6
VOB560-MIK665 - Part 2c
1 of 6
Experimental Treatment
170 Total Participants · 6 Treatment Groups
Primary Treatment: VOB560-MIK665 - Part 2a · No Placebo Group · Phase 1
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
What are the goals of this clinical research?
"The primary goal of this clinical trial is to assess the incidence of dose-limiting toxicities (DLTs) during the first cycle of treatment with VOB560 and MIK665 in combination. Secondary outcomes include apparent volume of distribution (Vz) of VOB560, overall response rate (ORR), and area under curve (AUC) of MIK665." - Anonymous Online Contributor
Are there harmful effects to taking VOB560-MIK665 - Part 2a?
"This medication, VOB560-MIK665 - Part 2a, is still in Phase 1 of clinical trials. This limits the available data regarding both its safety and efficacy, thus it was given a score of 1." - Anonymous Online Contributor
How many candidates are being enrolled in this study?
"That is correct. The website clinicaltrials.gov has the most recent information about this study, which began recruiting on 6/23/2021. As of 10/21/2022, the trial is still recruiting and looking for 170 participants from 1 location." - Anonymous Online Contributor
Are there any available positions for patients in this trial?
"The trial is currently active and looking for participants, with the most recent update on 10/21/2022. 170 patients are needed from 1 medical site." - Anonymous Online Contributor